Who are open-label recFSH's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Gonal-f® RFF, Placebo, gonadotropins in step-up regimen, MENOPUR; GONAL-F, rFSH drug dose, "Standard" rFSH dose, fix dose r-FSH (Gonal-f).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/open-label-recfsh.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

open-label recFSH — Competitive Intelligence Brief

open-label recFSH (open-label recFSH) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gonadotropin. Area: Reproductive Health.

phase 3 Gonadotropin FSH receptor Reproductive Health Biologic Live · refreshed every 30 min

Target snapshot

open-label recFSH (open-label recFSH) — Organon and Co. RecFSH stimulates follicular growth and ovulation in women with infertility.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
open-label recFSH TARGET	open-label recFSH	Organon and Co	phase 3	Gonadotropin	FSH receptor
Gonal-f® RFF	Gonal-f® RFF	Fertility Biotech AG	marketed	Gonadotropin; recombinant FSH	FSH receptor (FSHR)
Placebo, gonadotropins in step-up regimen	Placebo, gonadotropins in step-up regimen	University of Modena and Reggio Emilia	marketed	Gonadotropin	FSH receptor, LH receptor
MENOPUR; GONAL-F	MENOPUR; GONAL-F	Central Jutland Regional Hospital	marketed	Gonadotropin	FSH receptor (FSHR); LH receptor (LHCGR) for MENOPUR
rFSH drug dose	rFSH drug dose	Nina la Cour Freiesleben	marketed	Gonadotropin	FSH receptor (FSHR)
"Standard" rFSH dose	"Standard" rFSH dose	Nina la Cour Freiesleben	marketed	Gonadotropin	FSH receptor (FSHR)
fix dose r-FSH (Gonal-f)	fix dose r-FSH (Gonal-f)	Sisli Hamidiye Etfal Training and Research Hospital	marketed	Gonadotropin	FSH receptor (FSHR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Gonadotropin class)

Instituto Valenciano de Infertilidad, IVI VALENCIA · 4 drugs in this class
Sisli Hamidiye Etfal Training and Research Hospital · 3 drugs in this class
Organon and Co · 3 drugs in this class
Fundación Santiago Dexeus Font · 3 drugs in this class
Merck KGaA · 2 drugs in this class
Nina la Cour Freiesleben · 2 drugs in this class
IVI Madrid · 2 drugs in this class
Dunamenti REK Istenhegyi IVF Center · 1 drug in this class
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology · 1 drug in this class
Azienda USL Modena · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). open-label recFSH — Competitive Intelligence Brief. https://druglandscape.com/ci/open-label-recfsh. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab